TGFB1 and neoplasm: Also, the persistence of chronic inflammation, as observed in chronic viral hepatitis, plays a major role in determining the shift in the TGF-β1 signalling pathway from tumour suppression to fibrogenesis which accelerate liver fibrosis and increase the risk for HCC.